Mimedx Group Stock Market Value

MDXG Stock  USD 6.35  0.09  1.40%   
MiMedx's market value is the price at which a share of MiMedx trades on a public exchange. It measures the collective expectations of MiMedx Group investors about its performance. MiMedx is trading at 6.35 as of the 16th of April 2024. This is a -1.4 percent down since the beginning of the trading day. The stock's lowest day price was 6.34.
With this module, you can estimate the performance of a buy and hold strategy of MiMedx Group and determine expected loss or profit from investing in MiMedx over a given investment horizon. Check out MiMedx Correlation, MiMedx Volatility and MiMedx Alpha and Beta module to complement your research on MiMedx.
Symbol

MiMedx Group Price To Book Ratio

Is MiMedx's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MiMedx. If investors know MiMedx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MiMedx listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
4
Earnings Share
0.43
Revenue Per Share
2.76
Quarterly Revenue Growth
0.167
Return On Assets
0.113
The market value of MiMedx Group is measured differently than its book value, which is the value of MiMedx that is recorded on the company's balance sheet. Investors also form their own opinion of MiMedx's value that differs from its market value or its book value, called intrinsic value, which is MiMedx's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MiMedx's market value can be influenced by many factors that don't directly affect MiMedx's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MiMedx's value and its price as these two are different measures arrived at by different means. Investors typically determine if MiMedx is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MiMedx's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

MiMedx 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to MiMedx's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of MiMedx.
0.00
03/17/2024
No Change 0.00  0.0 
In 31 days
04/16/2024
0.00
If you would invest  0.00  in MiMedx on March 17, 2024 and sell it all today you would earn a total of 0.00 from holding MiMedx Group or generate 0.0% return on investment in MiMedx over 30 days. MiMedx is related to or competes with Monte Rosa, Design Therapeutics, Werewolf Therapeutics, Ikena Oncology, Stoke Therapeutics, Century Therapeutics, and Edgewise Therapeutics. MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare More

MiMedx Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure MiMedx's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess MiMedx Group upside and downside potential and time the market with a certain degree of confidence.

MiMedx Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for MiMedx's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as MiMedx's standard deviation. In reality, there are many statistical measures that can use MiMedx historical prices to predict the future MiMedx's volatility.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of MiMedx's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
3.976.438.89
Details
Intrinsic
Valuation
LowRealHigh
5.477.9210.39
Details
5 Analysts
Consensus
LowTargetHigh
10.9712.0613.39
Details
Earnings
Estimates (0)
LowProjected EPSHigh
0.030.040.06
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as MiMedx. Your research has to be compared to or analyzed against MiMedx's peers to derive any actionable benefits. When done correctly, MiMedx's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in MiMedx Group.

MiMedx Group Backtested Returns

MiMedx Group has Sharpe Ratio of -0.17, which conveys that the firm had a -0.17% return per unit of volatility over the last 3 months. MiMedx exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify MiMedx's mean deviation of 1.82, and Risk Adjusted Performance of (0.08) to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 2.0, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, MiMedx will likely underperform. MiMedx Group has an expected return of -0.4%. Please make sure to verify MiMedx Group total risk alpha, skewness, as well as the relationship between the Skewness and day median price , to decide if MiMedx Group performance from the past will be repeated at some point in the near future.

Auto-correlation

    
  0.58  

Modest predictability

MiMedx Group has modest predictability. Overlapping area represents the amount of predictability between MiMedx time series from 17th of March 2024 to 1st of April 2024 and 1st of April 2024 to 16th of April 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of MiMedx Group price movement. The serial correlation of 0.58 indicates that roughly 58.0% of current MiMedx price fluctuation can be explain by its past prices.
Correlation Coefficient0.58
Spearman Rank Test0.45
Residual Average0.0
Price Variance0.08

MiMedx Group lagged returns against current returns

Autocorrelation, which is MiMedx stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting MiMedx's stock expected returns. We can calculate the autocorrelation of MiMedx returns to help us make a trade decision. For example, suppose you find that MiMedx has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

MiMedx regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If MiMedx stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if MiMedx stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in MiMedx stock over time.
   Current vs Lagged Prices   
       Timeline  

MiMedx Lagged Returns

When evaluating MiMedx's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of MiMedx stock have on its future price. MiMedx autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, MiMedx autocorrelation shows the relationship between MiMedx stock current value and its past values and can show if there is a momentum factor associated with investing in MiMedx Group.
   Regressed Prices   
       Timeline  

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards MiMedx in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, MiMedx's short interest history, or implied volatility extrapolated from MiMedx options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether MiMedx Group is a strong investment it is important to analyze MiMedx's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact MiMedx's future performance. For an informed investment choice regarding MiMedx Stock, refer to the following important reports:
Check out MiMedx Correlation, MiMedx Volatility and MiMedx Alpha and Beta module to complement your research on MiMedx.
You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Complementary Tools for MiMedx Stock analysis

When running MiMedx's price analysis, check to measure MiMedx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MiMedx is operating at the current time. Most of MiMedx's value examination focuses on studying past and present price action to predict the probability of MiMedx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MiMedx's price. Additionally, you may evaluate how the addition of MiMedx to your portfolios can decrease your overall portfolio volatility.
Global Correlations
Find global opportunities by holding instruments from different markets
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Bonds Directory
Find actively traded corporate debentures issued by US companies
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
MiMedx technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of MiMedx technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of MiMedx trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...